Joshua Meier, SVP, Chief AI Officer, is responsible for leading the development of Absci’s cutting-edge generative AI models to design new protein therapeutics from scratch. Previously, he led the research platform for protein language modeling at Facebook AI Research where his group published a series of papers demonstrating the promise of unsupervised learning for protein sequence design. At Facebook, Joshua was the lead developer of the ESM-1b and ESM-1v models, which are widely used across biopharma today. Earlier in his career, Joshua worked on Generative AI at OpenAI, managed products for virtual reality at Google, and built MIT’s CRISPR-ML design platform. Joshua studied CS & Chemistry at Harvard.
Sign up to view 1 direct report
Get started